Please login to the form below

Not currently logged in
Email:
Password:

Pfizer veteran joins Dynavax board

Natale Ricciardi spent 39 years at pharma giant

Dynavax Natale RicciardiNatale Ricciardi has joined the board of Dynavax Technologies two years after retiring from Pfizer.

Ricciardi spent 39 years at Pfizer, advancing to president of the pharma giant's global manufacturing business and senior VP of its North American operations.

He was also a member of the Pfizer executive leadership team when he retired in 2011.

Dynavax, which focuses on developing products to prevent and treat infectious and inflammatory diseases, will benefit from this senior experience as it looks to bring to market its lead product candidate, the hepatitis B vaccine Heplisav.

"On behalf of Dynavax, we are delighted to welcome Nat to the board,” said Arnold Oronsky, chairman of the board at Dynavax.

“His experienced leadership, particularly in global manufacturing, will provide valuable insight to the company and we look forward to his contributions."

10th July 2013

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics